REQUEST A DEMO
Total
USD $0.00
Search more companies

Primula Pharma S.R.O. (Czech Republic)

Main Activities: Pharmacies and Drug Stores | Department Stores
Full name: Primula Pharma S.R.O. Profile Updated: June 27, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Primula Pharma S.R.O. is an enterprise located in Czech Republic, with the main office in Ostrava. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was established on February 14, 2007. The total number of employees is currently 6 - 9 (2024). The company’s latest financial report indicates a net sales revenue increase of 17.95% in 2025. Its’ total assets recorded a growth of 49.73%. The net profit margin of Primula Pharma S.R.O. decreased by 1.63% in 2025.

Headquarters
28. rijna 1142/168
Ostrava; Moravskoslezsky; Postal Code: 70900

Contact Details: Purchase the Primula Pharma S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Primula Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the Primula Pharma S.R.O. report to view the information.
Financial Auditors:
Purchase the Primula Pharma S.R.O. report to view the information.
Incorporation Date:
February 14, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Primula Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
17.95%
Total Operating Revenue
19.18%
Operating Profit
-61.72%
EBITDA
-64.5%
Net Profit/Loss for the Period
-77.94%
Total Assets
49.73%
Total Equity
6.25%
Operating Profit Margin
-2.42%
Net Profit Margin
-1.63%
Return on Equity (ROE)
21.67%
Debt / Equity
-25.36%
Quick Ratio
0.24%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?